A dual PI3K/mTOR inhibitor as potential therapeutic option for vulvar cancer

被引：0
|
作者：
Rodrigues, Lara [1 ]
Rodrigues, Bruna [1 ]
Giudice, Fernanda [1 ]
Baiocchi, Glauco [1 ]
Soares, Fernando Augusto [1 ]
Martins, Vilma [1 ]
Rocha, Rafael Malagoli [1 ]
机构：
[1] FUNDACAO AC CAMARGO, Sao Paulo, Brazil
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-2662
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2662
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Preclinical evaluation of novel PI3K/mTOR dual inhibitor SN202 as potential anti-renal cancer agent
    Wang, Wan
    Liao, Lidong
    Wang, Yujun
    Li, Hui
    Suo, Zili
    Long, Kai
    Tang, Peixiao
    CANCER BIOLOGY & THERAPY, 2018, 19 (11) : 1015 - 1022
  • [42] Synthesis of PF-04691502, a highly potent PI3K/mTOR dual inhibitor
    Hoffman, Jacqui
    Bailey, Simon
    Cheng, Hengmiao
    Kania, Robert
    Jai, Lei
    Nambu, Mitch
    Ninkovich, Sacha
    Pairish, Mason
    Srirangam, Jay
    Wang, Xiaolong
    Le, Phuong
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [43] DUAL TARGETING OF PI3K AND mTOR SIGNALING IN MEDULLOBLASTOMA
    Clymer, Jessica
    Eckerdt, Frank
    Bell, Jonathan
    Lulla, Rishi
    Goldman, Stewart
    Platanias, Leonidas
    NEURO-ONCOLOGY, 2016, 18 : 112 - 112
  • [44] Structural insights of a PI3K/mTOR dual inhibitor with the morpholino-triazine scaffold
    Takako Takeda
    Yanli Wang
    Stephen H. Bryant
    Journal of Computer-Aided Molecular Design, 2016, 30 : 323 - 330
  • [45] Structural insights of a PI3K/mTOR dual inhibitor with the morpholino-triazine scaffold
    Takeda, Takako
    Wang, Yanli
    Bryant, Stephen H.
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2016, 30 (04) : 323 - 330
  • [46] Targeting PI3K/mTOR signaling in cancer
    Arcaro, Alexandre
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [47] Enhancing anti cancer activity of PI103, a dual PI3K/mTOR inhibitor, by designing a self assembled Nanoformulation
    Roy, Bhaskar
    Sengupta, Poulomi
    Soni, Shivani
    Papa, Anne Laure
    Kopparam, Jawahar
    Sarangi, Sasmit
    Pandey, Ambarish
    Basu, Sudipta
    Sengupta, Shiladitya
    CANCER RESEARCH, 2012, 72
  • [48] Targeting PI3K/mTOR Signaling in Cancer
    Emerling, Brooke M.
    Akcakanat, Argun
    CANCER RESEARCH, 2011, 71 (24) : 7351 - 7359
  • [49] PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
    Li, HaiXia
    Zeng, JianFang
    Shen, Keng
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 290 (06) : 1067 - 1078
  • [50] BEZ235, A SELECTIVE PI3K/MTOR INHIBITOR, ENHANCES THE THERAPEUTIC EFFICACY OF DOXORUBICIN IN PANCREATIC CANCER
    Durrant, D.
    Das, A.
    Kukreja, R.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 303 - 304
12345